Table 3.
Therapy in the previous 12 months
| Paroxysmal | Persistent | Permanent | Tests# | ||||
|---|---|---|---|---|---|---|---|
| n = 994 | n = 944 | n = 1,525 | |||||
| n | Value | n | Value | n | Value | p | |
| Antiarrhythmic drugs class | |||||||
| IA | 13 | 1.3 | 13 | 1.4 | 7 | 0.5 | 0.0273 |
| Duration (months) | 9.4 ± 4.4 | 10.2 ± 3.1 | 9.3 ± 4.4 | 0.8008 | |||
| IC | 107 | 10.8 | 46 | 4.9 | 27 | 1.8 | <0.0001 |
| Duration (months) | 9.0 ± 4.1 | 7.0 ± 4.7 | 9.5 ± 4.3 | <0.0001 | |||
| II | 754 | 75.9 | 724 | 76.7 | 1,112 | 72.9 | 0.0122 |
| Duration (months) | 10.1 ± 3.4 | 9.8 ± 3.7 | 11.5 ± 1.9 | <0.0001 | |||
| III | 140 | 14.1 | 119 | 12.6 | 112 | 7.3 | <0.0001 |
| With ß-blocker activity | 54 | 5.4 | 52 | 5.5 | 76 | 5.0 | 0.7330 |
| Duration (months) | 8.9 ± 4.4 | 9.3 ± 3.7 | 10.5 ± 3.3 | 0.0593 | |||
| Other | 83 | 8.4 | 65 | 6.9 | 35 | 2.3 | <0.0001 |
| Duration (months) | 7.8 ± 4.4 | 6.7 ± 4.4 | 9.6 ± 3.3 | 0.0052 | |||
| IV | 130 | 13.1 | 140 | 14.8 | 273 | 17.9 | 0.0046 |
| Duration (months) | 9.8 ± 3.9 | 9.8 ± 3.6 | 11.5 ± 1.9 | <0.0001 | |||
| Digitalis | 204 | 20.5 | 262 | 27.8 | 547 | 35.9 | <0.0001 |
| Duration (months) | 9.4 ± 4.0 | 8.8 ± 4.1 | 11.3 ± 2.3 | <0.0001 | |||
#χ2-test or F test for analysis of variance (ANOVA)